← Leaderboards
Hanseok Ko
Johns Hopkins University
$8,865,346
Attributed
$9,315,659
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $981.8K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,315,659 · 12
By mechanism
R01$4,181,431 · 3
P50$3,465,357 · 4
R21$1,350,121 · 3
R03$318,750 · 2
Top collaborators
- Andrew S Mccallion4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Ted M. Dawson$31,695,689
- Michael K Lee$23,093,996
- Xiaobo Mao$12,683,437
- Amanda Maria Brown$10,521,177
- Andrew S McCallion$11,696,509
Others in their field
Top investigators on “Nerve Degeneration”
- Paul S. Aisen · Cognition Therapeutics, Inc.$113,855,136
- Reisa A. Sperling · Banner Health$83,196,776
- Randall J Bateman · Washington University$83,099,227
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$76,236,227
- Jose A Luchsinger · Columbia University Health Sciences$75,117,371
- Keith A. Johnson · Banner Health$70,466,464
Research focus
Nerve DegenerationParkinson DiseaseAlpha SynucleinPathologyPathogenesisBrainIn VivoLeadPlayInsightPathologicNeuron LossIn VitroGeneticDopaminergic NeuronTransgenic MiceAffectMutationSeveritiesProteinsNeuronsPhosphorylationMediatingMouse Model
Grant awards (31)
Unraveling microglial NOD2/RIPK2 signaling: Implications for neuroinflammation and neurodegeneration in Alzheimer's disease$622,086
R01 · FY2025 · AG · contact PI
Determining the critical time window of action of Parkinson mutant alpha synuclein expression in mice$204,688
R21 · FY2025 · NS
Characterization of AIMP2 variant-linked mouse model of Parkinson's disease$155,000
R03 · FY2025 · NS · contact PI
Determining the critical time window of action of Parkinson mutant alpha synuclein expression in mice$245,625
R21 · FY2024 · NS
Determination of the clinical relevance of Parkinson disease-associated intronic enhancer of the alpha-synuclein gene, in a novel mouse deletion model$204,688
R21 · FY2024 · NS
Validation of Small Molecule Enhancers of Mutant Glucocerebrosidase 1 Activity$163,750
R03 · FY2024 · NS · contact PI
Determination of the clinical relevance of Parkinson disease-associated intronic enhancer of the alpha-synuclein gene, in a novel mouse deletion model$245,625
R21 · FY2023 · NS
The role of NOD2/RIPK2 signaling in the pathogenesis of Parkinson's Disease$358,203
R01 · FY2022 · NS · contact PI
The role of NOD2/RIPK2 signaling in the pathogenesis of Parkinson's Disease$358,203
R01 · FY2021 · NS · contact PI
The role of NOD2/RIPK2 signaling in the pathogenesis of Parkinson's Disease$358,203
R01 · FY2020 · NS · contact PI
The role of NOD2/RIPK2 signaling in the pathogenesis of Parkinson's Disease$358,203
R01 · FY2019 · NS · contact PI
The role of c-Abl in the pathological transmission of alpha-synuclein from the gut to the brain$60,588
P50 · FY2019 · NS · contact PI
Animal and Neurobehavior Core$33,711
P50 · FY2019 · NS · contact PI
The role of NOD2/RIPK2 signaling in the pathogenesis of Parkinson's Disease$358,203
R01 · FY2018 · NS · contact PI
Understanding Mechanisms of a-synuclein pathology$307,395
P50 · FY2018 · NS · contact PI
Characterization and Validation of Mouse VPS35 Model of Parkinson's Disease$204,557
R21 · FY2018 · NS · contact PI
Glucocerebrosidase Biology and It's Role in Parkinson's Disease$354,375
R01 · FY2017 · NS · contact PI
Understanding Mechanisms of a-synuclein pathology$307,395
P50 · FY2017 · NS · contact PI
Characterization and Validation of Mouse VPS35 Model of Parkinson's Disease$244,938
R21 · FY2017 · NS · contact PI
Glucocerebrosidase Biology and It's Role in Parkinson's Disease$354,375
R01 · FY2016 · NS · contact PI
Understanding Mechanisms of a-synuclein pathology$307,395
P50 · FY2016 · NS · contact PI
Glucocerebrosidase Biology and It's Role in Parkinson's Disease$354,375
R01 · FY2015 · NS · contact PI
Understanding Mechanisms of a-synuclein pathology$307,395
P50 · FY2015 · NS · contact PI
Understanding Mechanisms of a-synuclein pathology$372,600
P50 · FY2014 · NS · contact PI
Glucocerebrosidase Biology and It's Role in Parkinson's Disease$350,830
R01 · FY2014 · NS · contact PI
Glucocerebrosidase Biology and It's Role in Parkinson's Disease$354,375
R01 · FY2013 · NS · contact PI
Mechanisms of Neurodegeneration in alpha-Synuclein Transgenic Mice$341,621
P50 · FY2013 · NS · contact PI
Mechanisms of Neurodegeneration in alpha-Synuclein Transgenic Mice$355,061
P50 · FY2012 · NS · contact PI
Mechanisms of Neurodegeneration in alpha-Synuclein Transgenic Mice$358,543
P50 · FY2011 · NS · contact PI
Mechanisms of Neurodegeneration in alpha-Synuclein Transgenic Mice$358,545
P50 · FY2010 · NS · contact PI
Mechanisms of Neurodegeneration in alpha-Synuclein Transgenic Mice$355,108
P50 · FY2009 · NS · contact PI